The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Insulin (Human Mixtard 30) is a hormone produced ...

A popular diabetes drug used by thousands will no longer be available in the UK but doctors are concerned by the effects on both their patients and the added financial burden on the NHS. Until very ...

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add £9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics ...

The withdrawal of Mixtard 30 by pharmaceutical manufacturer Novo Nordisk at the end of this year is expected to cause a great deal of confusion and extra expense to people suffering from diabetes as ...

Novo Nordisk announced it was withdrawing a major insulin drug Leading academics say the removal of Novo Nordisk's Mixtard 30 treatment, which some sufferers have relied for more than a decade, would ...

https://www.thehindubusinessline.com/news/novo-nordisk-clarifies-mixtard-insulin-vials-will-still-be-available-as-penfills-get-phased-out/article69479145.ece Copy ...

India’s diabetic population, particularly those on Novo Nordisk’s Human Mixtard insulin, are now apprehensive regarding changes in prescription practices. These concerns are attributed to various ...

Novo Nordisk has stated that its flagship insulin brand Mixtard will continue to be available in India in vial form, even as the company phases out other delivery formats such as Penfill cartridges.

Novo Nordisk will continue offering its top-selling insulin brand, Mixtard, in vial form in India, despite phasing out Penfill cartridges. This decision follows concerns about the discontinuation of ...